Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease

To evaluate the benefit of treatment with a physician administered intracanalicular dexamethasone insert in evaporative dry eye disease (DED) patients with meibomian gland disfunction (MGD) and underlying inflammation undergoing LipiFlow Thermal Pulsation.

Inclusion Criteria: A patient's study eye must meet the following criteria to be eligible for inclusion in the study: * 18 years of age or older * Evaporative DED with MGD and clinically significant inflammation * Willing and able to comply with clinic visits and study related procedures * Willing and able to sign the informed consent form Exclusion Criteria: A patient who meets any of the following criteria will be excluded from the study: * Patients under the age of 18. * Pregnancy (must be ruled out in women of child-bearing age with pregnancy test) * Active infectious systemic disease * Active infectious ocular or extraocular disease * Altered nasolacrimal flow of either acquired, induced, or congenital origin * Hypersensitivity to dexamethasone * Patient being treated with either topical, oral, or intravenous steroids * Patients with severe disease that warrants critical attention, deemed unsafe for the study by the investigator